C

CH Biotech R&D
6534

Last Price

Income Statement

Income Statement
Metric201920202021202220232024LTM
NT$1.515BNT$1.636BNT$1.684B
NT$254.733MNT$270.919MNT$278.547M
NT$1.26BNT$1.365BNT$1.406B
NT$305.235MNT$363.362MNT$370.503M
NT$389.001MNT$459.16MNT$492.954M
NT$565.86MNT$0MNT$0M
NT$565.86MNT$542.295MNT$542.329M
NT$0.412MNT$3.806MNT$-2.198M
NT$12.662MNT$46.861MNT$-98.62M
NT$13.074MNT$50.667MNT$-100.818M
NT$578.934MNT$592.962MNT$441.511M
NT$115.643MNT$117.272MNT$77.7M
NT$463.291MNT$476.386MNT$364.305M
NT$4.76NT$4.61NT$3.56
NT$4.73NT$4.61NT$3.53
NT$97.33MNT$103.327MNT$411.315M
NT$97.947MNT$103.327MNT$412.113M
NT$761.556MNT$797.707MNT$660.418M
NT$165.812MNT$189.75MNT$202.923M
NT$595.744MNT$607.957MNT$457.495M

Revenue And Expenses Breakdown

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.